INTECH Investment Management’s PTC Therapeutics PTCT Stock Holding History

INTECH Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.7M	Buy	57,581 +1,632	+3%	+$118K	0.04%	379
2026 Q1	$3.81M	Buy	55,949 +21,258	+61%	+$1.51M	0.04%	414
2025 Q4	$2.64M	Buy	34,691 +6,413	+23%	+$466K	0.02%	616
2025 Q3	$1.74M	Sell	28,278 -11,029	-28%	-$574K	0.02%	855
2025 Q2	$1.92M	Hold	39,307	–	–	0.02%	785
2025 Q1	$2M	Buy	39,307 +15,167	+63%	+$757K	0.02%	754
2024 Q4	$1.09M	Buy	24,140 +5,334	+28%	+$228K	0.01%	1082
2024 Q3	$698K	Buy	+18,806	New	+$630K	0.01%	1028

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

INTECH Investment Management's PTCT Position: Q2 2026 in Review

INTECH Investment Management increased its PTC Therapeutics (PTCT) stake by 2.9% in Q2 2026, buying an estimated $118K and bringing the position to 57,581 shares worth $4.7M. The position accounts for 0.04% of the portfolio, ranked #379.

INTECH Investment Management first reported a position in PTCT in Q3 2024 and has held it in 8 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

INTECH Investment Management held 57,581 shares of PTC Therapeutics worth $4.7M as of Q2 2026.
INTECH Investment Management bought 1,632 PTC Therapeutics shares in Q2 2026, an estimated $118K.
PTC Therapeutics made up 0.04% of INTECH Investment Management's portfolio in Q2 2026, its #379 holding.
INTECH Investment Management first reported a position in PTC Therapeutics in Q3 2024 and has held it in 8 quarters since.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.